Literature DB >> 12110179

Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

Chengming Zhu1, Kevin D Mills, David O Ferguson, Charles Lee, John Manis, James Fleming, Yijie Gao, Cynthia C Morton, Frederick W Alt.   

Abstract

Amplification of large genomic regions associated with complex translocations (complicons) is a basis for tumor progression and drug resistance. We show that pro-B lymphomas in mice deficient for both p53 and nonhomologous end-joining (NHEJ) contain complicons that coamplify c-myc (chromosome 15) and IgH (chromosome 12) sequences. While all carry a translocated (12;15) chromosome, coamplified sequences are located within a separate complicon that often involves a third chromosome. Complicon formation is initiated by recombination of RAG1/2-catalyzed IgH locus double-strand breaks with sequences downstream of c-myc, generating a dicentric (15;12) chromosome as an amplification intermediate. This recombination event employs a microhomology-based end-joining repair pathway, as opposed to classic NHEJ or homologous recombination. These findings suggest a general model for oncogenic complicon formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110179     DOI: 10.1016/s0092-8674(02)00770-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  184 in total

Review 1.  The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies.

Authors:  Martin J S Dyer
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

2.  Structure of a palindromic amplicon junction implicates microhomology-mediated end joining as a mechanism of sister chromatid fusion during gene amplification.

Authors:  Yukiko Okuno; Peter J Hahn; David M Gilbert
Journal:  Nucleic Acids Res       Date:  2004-02-02       Impact factor: 16.971

Review 3.  Artemis: guarding small children and, now, the genome.

Authors:  Vicky L Brandt; David B Roth
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

4.  Biochemical evidence for Ku-independent backup pathways of NHEJ.

Authors:  Huichen Wang; Ange Ronel Perrault; Yoshihiko Takeda; Wei Qin; Hongyan Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

5.  Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas.

Authors:  Nicolas Vogt; Sandrine-Hélène Lefèvre; Françoise Apiou; Anne-Marie Dutrillaux; Andrej Cör; Pascal Leuraud; Marie-France Poupon; Bernard Dutrillaux; Michelle Debatisse; Bernard Malfoy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

6.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

7.  Chromosomal location targets different MYC family gene members for oncogenic translocations.

Authors:  Monica Gostissa; Sheila Ranganath; Julia M Bianco; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

8.  Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.

Authors:  Monica Gostissa; Julia M Bianco; Daniel J Malkin; Jeffery L Kutok; Scott J Rodig; Herbert C Morse; Craig H Bassing; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  Proteasome activator PA200 is required for normal spermatogenesis.

Authors:  Bernard Khor; Andrea L Bredemeyer; Ching-Yu Huang; Isaiah R Turnbull; Ryan Evans; Leonard B Maggi; J Michael White; Laura M Walker; Kay Carnes; Rex A Hess; Barry P Sleckman
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.